Zobrazeno 1 - 10
of 72
pro vyhledávání: '"Elisabeth Korn"'
Autor:
Christian Fuchs
Publikováno v:
tripleC: Communication, Capitalism & Critique, Vol 22, Iss 2, Pp 534-549 (2024)
This paper is a reply to Elisabeth Korn and Jens Schröter’s essay “On a Potential Paradox of Public Service Media” which is part of tripleC’s special issue “Critical Perspectives on Digital Capitalism: Theories and Praxis”. My reflection
Externí odkaz:
https://doaj.org/article/f80d417513d74e24ad5b4e0534024d60
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Elisabeth Korn, Jens Schröter
Publikováno v:
tripleC: Communication, Capitalism & Critique, Vol 22, Iss 2, Pp 550-566 (2024)
This paper is a rejoinder to Christian Fuchs’ “Democracy, the Internet, and Capitalism,” published in tripleC as a reply to our essay “On a Potential Paradox of Public Service Media” (2024), which was part of tripleC’s special issue “Cr
Externí odkaz:
https://doaj.org/article/fba6788a8b1a454eaa1e5801a513ef13
Autor:
Yvonne G. Weber, Jürgen Sperner, Steffen Grüninger, Sarah Weckhuysen, Julian Schubert, Kerstin Hallmann, Wolfram S. Kunz, Anne Hofmann-Peters, Elisabeth Korn-Merker, René Madeleyen, Christian E. Elger, Felicitas Becker, Arvid Suls, Helen Cross, Holger Lerche
Publikováno v:
Epilepsy research
In the recent years, several neurological syndromes related to defects of the glucose transporter type 1 (Glut1) have been descried. They include the glucose transporter deficiency syndrome (Glut1-DS) as the most severe form, the paroxysmal exertion-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::70f1ac5e6691db3e27a0742acf1848ca
https://doi.org/10.1016/j.eplepsyres.2015.04.012
https://doi.org/10.1016/j.eplepsyres.2015.04.012
Autor:
Gerd Kurlemann, Theodor W. May, Christoph Härtel, Joachim Opp, Adelheid Wiemer-Kruel, Dietz Rating, Elisabeth Korn-Merker, Ingrid Tuxhorn, Ulrich Bettendorf, Gunther Gross-Selbeck, Gerhard Kluger, U. Brandl
Publikováno v:
Seizure. 14:476-484
Summary Purpose: To evaluate the efficacy and tolerability of Levetiracetam (LEV) in a large pediatric cohort with drug-resistant epilepsy from a prospective multicenter observational study. Methods: We report the results of a multicenter observation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5dac15e9276650b665d7f1352fd584e0
https://doi.org/10.1016/j.seizure.2005.08.002
https://doi.org/10.1016/j.seizure.2005.08.002
Autor:
G. Kurlemann, Elisabeth Korn-Merker, Ingrid Tuxhorn, G. Kluger, J. Opp, G. Groß-Selbeck, Adelheid Wiemer-Kruel
Publikováno v:
Zeitschrift f�r Epileptologie. 16:302-306
In einer retrospektiven Anwendungsbeobachtung erfassten wir 157 Therapieverlaufe mit LEV bei Kindern mit therapieschwierigen Epilepsien. 7 Patienten wurden anfallsfrei, 20 zeigten eine Anfallsreduktion um 76–99%, 11 zeigten eine Anfallsreduktion um
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::70008725ec5c04ab714adf692e09c656
https://doi.org/10.1007/s10309-003-0041-5
https://doi.org/10.1007/s10309-003-0041-5
Publikováno v:
Clinical Pharmacokinetics. 42:1023-1042
Oxcarbazepine is an antiepileptic drug with a chemical structure similar to carbamazepine, but with different metabolism. Oxcarbazepine is rapidly reduced to 10,11-dihydro-10-hydroxy-carbazepine (monohydroxy derivative, MHD), the clinically relevant
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aafa58fc4d6de57a3f91c6c45bcde32f
https://doi.org/10.2165/00003088-200342120-00002
https://doi.org/10.2165/00003088-200342120-00002
Publikováno v:
Epilepsy Research. 38:27-32
Purpose : To evaluate the efficacy and safety of gabapentin (GBP) in partial epilepsy in children. Methods : We performed a prospective open label add-on study in 52 children and adolescents (age 1.8–17.5 years, mean 11.1 years) with refractory par
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::52b796a43a7c442f1304787c91ec7350
https://doi.org/10.1016/s0920-1211(99)00063-7
https://doi.org/10.1016/s0920-1211(99)00063-7
Publikováno v:
Journal of Epilepsy. 11:355-360
Oxcarbazepine (OCBZ) is one of the new antiepileptic drugs (AEDs) currently available in several countries. While it is rated as having fewer side effects than carbamazepine (CBZ) there has been a paucity of studies in children. We retrospectively re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4409f50283d8b23e6ab5943ad20fd478
https://doi.org/10.1016/s0896-6974(98)00041-3
https://doi.org/10.1016/s0896-6974(98)00041-3
Autor:
Elisabeth Korn-Merker, Bernhard Rambeck, Thomas Mayer, Christian Brandt, Nils Holert, Theodor W. May, Rainer Boor, Uwe Jürgens
Publikováno v:
Therapeutic drug monitoring. 34(4)
Stiripentol (STP) was approved as an orphan drug in 2007 in Europe as adjunctive therapy with valproic acid (VPA) and clobazam (CLB) for Dravet syndrome. Dravet syndrome is a highly pharmacoresistant form of epilepsy, which starts in early childhood.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::17236a868cb32f4d0de490b380671a16
https://pubmed.ncbi.nlm.nih.gov/22743350
https://pubmed.ncbi.nlm.nih.gov/22743350